Tag: test for colon cancer

New ADLT Payment Rate May Force Lab to Close

By Joseph Burns, from the Volume XXII NO. 15 - October 26, 2015 issue

CEO SUMMARY: Four Medicare Administrative Contractors currently pay $2,821 for CareDx’s AlloMap test. But under the proposal that CMS issued last month to overhaul the clinical lab fee schedule, CareDx would get only $644. Such a steep price cut would put the lab out of business because the payment would be lower than the cost

View Article

“November 13, 2000 Intelligence: Late Breaking Lab News”

By R. Lewis Dark, from the Volume VII No. 16 - November 13, 2000 issue

Last Thursday was the day Dynacare, Inc. hoped to place its initial public offering. Dynacare seeks to raise as much as $89 million by selling its shares to the public. However, the unresolved presidential election on Tuesday caused turmoil on the stock market during the remainder of the week. As this issue of THE DARK REPORT

View Article

Volume XXVI No. 2 – February 4, 2019

NOW THAT MOST HOSPITALS ARE INCLUDED as applicable laboratories that must report their PAMA private payer lab test price data to the Centers for Medicare and Medicaid Services, managers of those labs will benefit from the incisive analysis in this issue of the lessons learned during the 2017 PAMA reporting cycle. THE DARK REPORT further offers recommendations on how labs can do a better job of gathering and reporting their own data to CMS. Also, TDR delivers an exclusive analysis of why the Government Accounting Office's assertion that CMS will be paying billions more for Part B clinical lab tests is simply wrong.

See the full table of contents

Tag: test for colon cancer

Enter Your Login Credentials